Chronic dialysis patients have high risk for pulmonary embolism

American Journal of Kidney Diseases

Volumn 39, Issue 5, 2002, Pages 1011-1017

  Tveit, Daniel P ^a,b,c   Hypolite, Iman O ^a,b,c   Hshieh, Paul ^a,b,c   Cruess, David ^a,b,c   Agodoa, Lawrence Y ^a,b,c   Welch, Paul G ^a,b,c   Abbott, Kevin C ^a,b,c  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Complications; Dialysis; Hemodialysis (HD); National Center for Health Statistics (NCHS); Peritoneal dialysis (PD); Pulmonary embolism; US Renal Data System (USRDS)

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; COMORBIDITY; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INCIDENCE; KIDNEY FAILURE; LONG TERM CARE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

EID: 0036236742     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2002.32774     Document Type: Article

References (37)

1. Venous thromboembolism
2. Deep vein thrombosis in end-stage renal disease
3. Acute complications during hemodialysis
4. Pulmonary embolism. Low incidence in chronic renal failure
5. Comparative pathologic-anatomic study of cases of global renal insufficiency with and without preceding dialysis
6. Venous thromboembolism in end-stage renal disease
7. Pulmonary embolism in end stage renal disease
8. Hypercoagulability in dialysis patients: Fact or fiction?
9. Neuraminadase-like activity in sera of uremic anemic patients
10. Cause of death in acute renal failure
11. Abnormal platelet cytoskeletal assembly in hemodialyzed patients results in deficient tyrosine phosphorylation signaling
12. Plasma and platelet von Willebrand factor abnormalities in patients with uremia: Lack of correlation with uremic bleeding
13. Hematologic aspects of end-stage renal failure
14. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis
15. Acute pulmonary embolism: Clinical outcomes in the International Cooperative Pulmonary Embolism Registry
16. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: Final report of the Lyon Diet Heart Study
17. Long-term medical complications in patients surviving > or = 5 years after liver transplant
18. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here?
19. The microinflammatory state in uremia: Causes and potential consequences
20. Activated protein C (APC). Plasma levels of activated protein C-protein C inhibitor complex in patients with hypercoagulable states
21. Increased activation of protein C, but lower plasma levels of free, activated protein C in uraemic patients: Relationship with systemic inflammation and haemostatic activation
22. The activity of t-PA is markedly decreased in chronic renal failure
23. Hemostasis, platelet function and serotonin in acute and chronic renal failure
24. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis
25. Hemostatic disorder of uremia: The platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis
26. Risk of suicide among persons with AIDS. A national assessment
27. Accuracy of diagnostic coding for Medicare patients under the prospective-payment system
28. Validation of comorbid conditions on the end-stage renal disease medical evidence report: The CHOICE study. Choices for Healthy Outcomes in Caring for ESRD
29. Comparability of national death index plus and standard procedures for determining causes of death in epidemiologic studies
30. Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States
31. Cardiovascular disease and chronic renal disease: A new paradigm
32. Septicemia in diabetic hemodialysis patients: Comparison of incidence, risk factors, and mortality with nondiabetic hemodialysis patients
33. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
34. Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: A multicenter study